Gene · 64006
Papers4,423
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,423
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Structural evolution of Delta lineage of SARS-CoV-2. | Int J Biol Macromol | 2023 | 36435470 | PubTator, text mining | PubMed |
| Can the triumph of mRNA vaccines against COVID-19 be extended to other viral infections of humans and domesticated animals? | Microbes Infect | 2023 | 36435367 | PubTator, text mining | PubMed |
| A review on structural, non-structural, and accessory proteins of SARS-CoV-2: Highlighting drug target sites. | Immunobiology | 2023 | 36434912 | PubTator, text mining | PubMed |
| How Protective are Antibodies to SARS-CoV-2, the Main Weapon of the B-Cell Response? | Stem Cell Rev Rep | 2023 | 36422774 | PubTator, text mining | PubMed |
| Optimization of the expression of the main protease from SARS-CoV-2. | Protein Expr Purif | 2023 | 36403706 | PubTator, text mining | PubMed |
| COVID-19 diagnostics: Molecular biology to nanomaterials. | Clin Chim Acta | 2023 | 36403665 | PubTator, text mining | PubMed |
| Genome characterization, phylogenomic assessment and spatio-temporal dynamics study of highly mutated BA variants from India. | Indian J Med Microbiol | 2023 | 36400646 | PubTator, text mining | PubMed |
| Recombinant highly antigenic truncated fusion-based protein as a diagnostic antigen for anti-SARS-CoV-2 nucleocapsid antibody ELISA. | Protein Expr Purif | 2023 | 36379348 | PubTator, text mining | PubMed |
| Protein structure-based in-silico approaches to drug discovery: Guide to COVID-19 therapeutics. | Mol Aspects Med | 2023 | 36371228 | PubTator, text mining | PubMed |
| Structural remodeling of SARS-CoV-2 spike protein glycans reveals the regulatory roles in receptor-binding affinity. | Glycobiology | 2023 | 36370046 | PubTator, text mining | PubMed |
| Determination of binding affinity of tunicamycin with SARS-CoV-2 proteins: Proteinase, protease, nsp2, nsp9, ORF3a, ORF7a, ORF8, ORF9b, envelope and RBD of spike glycoprotein. | Vacunas | 2023 | 36349218 | PubTator, text mining | PubMed |
| Zebrafish models of COVID-19. | FEMS Microbiol Rev | 2023 | 36323404 | PubTator, text mining | PubMed |
| COVID-19 drugs: potential interaction with ATP-binding cassette transporters P-glycoprotein and breast cancer resistance protein. | J Pharm Investig | 2023 | 36320434 | PubTator, text mining | PubMed |
| SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein. | Mol Psychiatry | 2023 | 36316366 | PubTator, text mining | PubMed |
| Heparin mimetics as potential intervention for COVID-19 and their bio-manufacturing. | Synth Syst Biotechnol | 2023 | 36313216 | PubTator, text mining | PubMed |
| Clinical characteristics of pediatric cases infected with the SARS-CoV-2 Omicron variant in a tertiary children's medical center in Shanghai, China. | World J Pediatr | 2023 | 36251118 | PubTator, text mining | PubMed |
| Smart healthcare: A prospective future medical approach for COVID-19. | J Chin Med Assoc | 2023 | 36227021 | PubTator, text mining | PubMed |
| SARS-CoV-2 Vaccines: Types, Working Principle, and Its Impact on Thrombosis and Gastrointestinal Disorders. | Appl Biochem Biotechnol | 2023 | 36222988 | PubTator, text mining | PubMed |
| An integrated computational approach towards the screening of active plant metabolites as potential inhibitors of SARS-CoV-2: an overview. | Struct Chem | 2023 | 36212707 | PubTator, text mining | PubMed |
| Optical reflectometric measurement of SARS-CoV-2 (COVID-19) RNA based on cationic cysteamine-capped gold nanoparticles. | Opt Laser Technol | 2023 | 36212170 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/64006/papers?page=33